Is aripiprazole a key to unlock anorexia nervosa?: A case series

Abstract

Abstract Aripiprazole contributes an increase in body mass index and attenuation in anorexia nervosa (AN) symptoms, leading clinical improvements with lower side‐effect profile; but it is not enough to cure comorbid depressive symptoms in AN.

Keywords

• anorexia nervosa
• aripiprazole
• BMI
• case series
• depression
• follow‐up